Skip to main content
Figure 3 | Journal of Translational Medicine

Figure 3

From: Dovitinib preferentially targets endothelial cells rather than cancer cells for the inhibition of hepatocellular carcinoma growth and metastasis

Figure 3

Dovitinib inhibited the proliferation of endothelial cells at pharmacologically relevant concentration. A) Dovitinib inhibited the proliferation of endothelial cells under VEGF, PDGF-BB dependent or normal conditions by MTS assay; results were normalized to DMSO controls. B) Proliferation of MHCC-97H and SMMC7721 HCC cells was inhibited only at high concentrations of dovitinib.

Back to article page